Home Applications 215137 Application 215137
Type ANDA
Sponsor AUROBINDO PHARMA Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 DEFERASIROX DEFERASIROX GRANULE;ORAL 90MG No No 002 DEFERASIROX DEFERASIROX GRANULE;ORAL 180MG No No 003 DEFERASIROX DEFERASIROX GRANULE;ORAL 360MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A215137-001 DEFERASIROX DEFERASIROX 90MG GRANULE / ORAL AB 2025-09-08 A215137-002 DEFERASIROX DEFERASIROX 180MG GRANULE / ORAL AB 2025-09-08 A215137-003 DEFERASIROX DEFERASIROX 360MG GRANULE / ORAL AB 2025-09-08
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A215137-001 DEFERASIROX 90MG GRANULE / ORAL AB 2025-09-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A215137-002 DEFERASIROX 180MG GRANULE / ORAL AB 2025-09-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A215137-003 DEFERASIROX 360MG GRANULE / ORAL AB 2025-09-08 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215137-001 DEFERASIROX 90MG GRANULE / ORAL AB 2025-09-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215137-002 DEFERASIROX 180MG GRANULE / ORAL AB 2025-09-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215137-003 DEFERASIROX 360MG GRANULE / ORAL AB 2025-09-08 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A215137-001 DEFERASIROX 90MG GRANULE / ORAL AB 2025-09-08 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A215137-002 DEFERASIROX 180MG GRANULE / ORAL AB 2025-09-08 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A215137-003 DEFERASIROX 360MG GRANULE / ORAL AB 2025-09-08 a50c72e98297…
Observed Orange Book normalized TE history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join DEFERASIROX DEFERASIROX Aurobindo Pharma Limited c220484e-1e6a-4a0c-a221-60223f3bc24c 2025-09-09 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 215137 application number: ANDA215137